(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of 4.31% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.6%.
Masimo's revenue in 2024 is $2,048,100,000.On average, 5 Wall Street analysts forecast MASI's revenue for 2024 to be $111,228,342,943, with the lowest MASI revenue forecast at $111,118,706,863, and the highest MASI revenue forecast at $111,355,757,847. On average, 5 Wall Street analysts forecast MASI's revenue for 2025 to be $117,670,732,556, with the lowest MASI revenue forecast at $116,938,096,860, and the highest MASI revenue forecast at $118,948,797,168.
In 2026, MASI is forecast to generate $124,844,382,124 in revenue, with the lowest revenue forecast at $122,642,136,155 and the highest revenue forecast at $128,473,167,048.